Cimt denied as duplicate or overlapping therapy by Cigna?

Cigna's specific coverage criteria for cimt are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denies CIMT as Duplicate Therapy — and Why You Can Appeal

Constraint-Induced Movement Therapy (CIMT) is a structured, intensive rehabilitative intervention for motor impairment, most commonly following stroke or other upper-limb neurological injury. Cigna may issue a duplicate-therapy denial when the patient is concurrently receiving — or has recently completed — conventional occupational therapy or another form of upper-extremity rehabilitation, asserting that CIMT overlaps in purpose with an already-covered service.

This denial is frequently overturned because CIMT is not simply "more of the same" occupational therapy. It involves a distinct clinical protocol — restraint of the less-affected limb combined with intensive massed practice of the affected limb — that targets cortical neuroplasticity in a way that conventional therapy does not replicate. Published rehabilitation guidelines from organizations such as the American Heart Association/American Stroke Association recognize CIMT as a distinct, evidence-supported modality.

## Federal Appeal Rights

• Internal appeal (ERISA §503 / ACA): File within 180 days of denial. Cigna must respond within 60 days (30 days for pre-service).
• External review (ACA §2719): If the internal appeal is denied, request external review within approximately 4 months. The independent reviewer evaluates against generally accepted clinical standards, not just Cigna's internal coverage criteria.
• Expedited review: Available within 72 hours if the patient's condition is urgent.

## What to Gather

1. Diagnosis and functional status: Physician documentation of diagnosis (e.g., stroke, hemiparesis), time since onset, and current upper-limb functional deficits using standardized clinical measures noted in the chart. 2. Clinical distinction letter: A letter from the treating therapist or physiatrist explaining how CIMT differs mechanistically and clinically from the concurrent or prior therapy — why it is a different intervention, not a duplicate. 3. Prior therapy records: Documentation of what conventional therapy was provided, its goals, duration, and outcomes — to show CIMT addresses a distinct therapeutic goal. 4. Guideline support: Reference to applicable rehabilitation guideline recommendations (e.g., AHA/ASA stroke rehabilitation guidelines) supporting CIMT as a distinct, indicated modality for this patient's presentation. 5. Cigna's published coverage policy: Identify the specific duplicate-therapy criterion invoked and map your documentation to show CIMT does not meet that definition.

## Criteria-Mapping Structure

| Cigna Duplicate-Therapy Criterion | Your Documentation | |---|---| | Claimed overlap with concurrent/prior therapy | Explanation of mechanistic and protocol distinction | | Same therapeutic goal as covered service | Separate, documented goals for CIMT vs. prior therapy | | Guideline support for distinct modality | Prescriber/therapist letter citing AHA/ASA or equivalent | | Functional deficit justifying additional intervention | Chart-documented deficit measures and functional goals |

The core argument is specificity: CIMT is a named, guideline-recognized intervention with a distinct protocol, not an interchangeable substitute for general occupational therapy.